The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Oligonucleotide Synthesis Services Market Through 2030?

The oligonucleotide synthesis services market size has experienced strong growth in recent years. This market is forecasted to increase from $2.93 billion in 2025 to $3.21 billion in 2026, at a compound annual growth rate (CAGR) of 9.7%. Historically, this expansion has been driven by the rising use of PCR and sequencing, the broadening of molecular biology research, an increase in genomic testing, greater academic genomics funding, and an expansion of biotech research and development activity.

The oligonucleotide synthesis services market is set to experience robust expansion over the next few years. It is projected to achieve a value of $4.7 billion by 2030, advancing at a compound annual growth rate (CAGR) of 10.0%. This anticipated growth is primarily fueled by the expansion of gene and cell therapy pipelines, increasing demand for CRISPR and gene editing, the broadening application of nucleic acid therapeutics, greater adoption of precision diagnostics, and the scaling up of clinical oligo production. Prominent trends for the forecast period include high-throughput custom oligo production, offerings for modified and labeled oligonucleotide services, GMP-grade oligo manufacturing, rapid turnaround gene editing oligos, and sophisticated oligo purification workflows.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33245&type=smp

What Important Drivers Are Powering The Oligonucleotide Synthesis Services Market Growth?

A growing emphasis on personalized medicine is projected to stimulate the expansion of the oligonucleotide synthesis services market in the future. This medical approach tailors treatment and prevention strategies to an individual’s unique genetic, biological, and lifestyle attributes. Its adoption is rising, fueled by breakthroughs in genomics and molecular diagnostics that enable therapies to be customized to an individual’s genetic makeup, leading to improved patient results. Oligonucleotide synthesis services facilitate personalized medicine through the quick and accurate creation of bespoke DNA or RNA sequences, which are vital for patient-specific diagnostics, precise therapies, and gene-oriented treatments, thus supporting interventions tailored to an individual’s genetic profile. As an illustration, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, showed that in 2023, the FDA sanctioned 16 novel personalized treatments for patients with rare diseases, an increase from six in 2022. The newly sanctioned personalized treatments for 2023 also comprised seven cancer medications and three for other illnesses and conditions. Consequently, the heightened focus on personalized medicine is a key driver for the growth of the oligonucleotide synthesis services market.

What Segment Types Are Included In The Oligonucleotide Synthesis Services Market Analysis?

The oligonucleotide synthesis services market covered in this report is segmented –

1) By Type Of Oligonucleotide: Deoxyribonucleic Acid Oligonucleotides; Ribonucleic Acid Oligonucleotides; Peptide Nucleic Acids (PNAs); Locked Nucleic Acids (LNAs); Other Synthetic Nucleotides

2) By Synthesis Method: Solid Phase Synthesis; Liquid Phase Synthesis; Microarray Based Synthesis; Oligonucleotide Synthesis Via Automated Synthesizers; Enzymatic Synthesis

3) By Purity Level: Standard Purity; High Purity; Ultra High Purity; Custom Purity Solutions; Quality Control Measures

4) By Application: Diagnostics; Therapeutics; Research And Development; Gene Editing; Vaccine Development

5) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations (CROs); Clinical Laboratories

Subsegments:

1) By Deoxyribonucleic Acid Oligonucleotides: Standard Deoxyribonucleic Acid Oligonucleotides; Modified Deoxyribonucleic Acid Oligonucleotides; Phosphorothioate Deoxyribonucleic Acid Oligonucleotides; Methylated Deoxyribonucleic Acid Oligonucleotides

2) By Ribonucleic Acid Oligonucleotides: Standard Ribonucleic Acid Oligonucleotides; Modified Ribonucleic Acid Oligonucleotides; Small Interfering Ribonucleic Acid Oligonucleotides; Micro Ribonucleic Acid Oligonucleotides

3) By Peptide Nucleic Acids: Standard Peptide Nucleic Acids; Modified Peptide Nucleic Acids; Functionalized Peptide Nucleic Acids

4) By Locked Nucleic Acids: Standard Locked Nucleic Acids; 2′-O-Methyl Locked Nucleic Acids; Gapmer Locked Nucleic Acids

5) By Other Synthetic Nucleotides: Morpholino Oligonucleotides; Phosphoramidite Oligonucleotides; Xeno Nucleic Acid Oligonucleotides; Synthetic Aptamers

Which Trends Are Affecting The Oligonucleotide Synthesis Services Market Framework?

Leading entities within the oligonucleotide synthesis services sector are prioritizing the expansion of DNA and RNA manufacturing capabilities to advance therapeutic and diagnostic investigations. These capabilities encompass sophisticated techniques for generating and scaling premium genetic material, which are essential for facilitating scientific inquiry, diagnostic procedures, and the formulation of biopharmaceutical treatments. A notable illustration is Oligo Factory Inc., a US-based manufacturing firm, which introduced a low-scale oligo synthesis feature in May 2025, specifically designed to extend assistance to professionals in therapeutic and diagnostic research and development. This innovation facilitates the production of custom DNA/RNA in small batches, beginning at 50 nmol, catering to initial research and development phases across therapeutics, diagnostics, qPCR, NGS, and preclinical trials. Its advantages include reduced expenses and waste, a rapid turnaround time (4 weeks or less) adhering to GMP or ISO 13485 quality standards, and the provision of continuous scaling support through portfolios like FactorTx, eliminating the need for vendor transitions. This flexibility is particularly advantageous for researchers who require prototypes rather than extensive minimum order quantities.

Which Firms Are Competing In The Oligonucleotide Synthesis Services Market?

Major companies operating in the oligonucleotide synthesis services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., QIAGEN N.V., Integrated DNA Technologies Inc., Sangon Biotech (Shanghai) Co. Ltd., Ajinomoto Co. Inc., Twist Bioscience Corporation, Sigma-Aldrich Co. LLC, Aldevron LLC, Bioneer Corporation, GenScript Biotech Corporation, BBI Life Sciences Ltd., Takara Bio Inc., BioServe Biotechnologies Ltd., Eurofins Genomics Germany GmbH, Bio-Synthesis Inc., TriLink BioTechnologies LLC, BioBasic Inc., Biosearch Technologies Inc., JenaBioscience GmbH, Geneworks Pty Ltd., HUWEL Life Science Co. Ltd., and SynoLigo Pvt. Ltd.

Access The Complete Oligonucleotide Synthesis Services Market Report:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-services-market-report

Which Region Holds The Largest Share In The Oligonucleotide Synthesis Services Market?

North America was the largest region in the oligonucleotide synthesis services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Oligonucleotide Synthesis Services Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model